• OPEN AN ACCOUNT
Indian Indices
Sensex
82,225.92 -1,068.74
( -1.28%)
Global Indices
Nasdaq
48,816.07 -830.91
(-1.67%)
Dow Jones
6,858.07 -72.44
(-1.05%)
Hang Seng
57,337.44 511.74
(0.90%)
Nikkei 225
10,686.70 1.96
(0.02%)
Forex
USD-INR
90.72 -0.31
(-0.34%)
EUR-INR
106.89 -0.33
(-0.31%)
GBP-INR
122.26 -0.41
(-0.34%)
JPY-INR
0.59 0.00
(-0.41%)

EQUITY - MARKET SCREENER

Glaxosmithkline Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
500660
INE159A01016
100.5174369
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLAXO
44.9
44678.3
EPS(TTM)
Face Value()
Div & Yield %
58.74
10
2.05
 

Salem Erode Investments reports standalone net loss of Rs 1.20 crore in the September 2025 quarter
Nov 13,2025
Net Loss of Salem Erode Investments reported to Rs 1.20 crore in the quarter ended September 2025 as against net loss of Rs 0.85 crore during the previous quarter ended September 2024. Sales declined 25.83% to Rs 0.89 crore in the quarter ended September 2025 as against Rs 1.20 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales0.891.20 -26
OPM %-56.187.50 -
PBDT-0.92-0.45 -104
PBT-1.23-0.87 -41
NP-1.20-0.85 -41